Transforming patient health through personalized, predictive care
Biofourmis Achieves Unicorn status!
$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
Transforming patient health through personalized, predictive care
Patient Satisfaction Score
99%Client Satisfaction Score
Care teams stay with patients after discharge and in between office visits with an easy-to-use platform that provides personalized treatment plans for immediate medical needs and chronic conditions.
Improve clinical outcomes by using continuous patient data and FDA-cleared analytics to provide care teams vital insights to take action.
Advance drug development and develop digital therapies that work in conjunction with high-value drugs to improve efficacy.
Reduce healthcare costs and readmission rates with platforms that deliver hospital-level care and attention in a patient’s home.
Our award-winning solutions improve patient health across the care continuum
Provide personalized care in the comfort of a patient’s home with Hospital@Home, Remote Patient Monitoring and Chronic Care solutions.
Enhance drug therapies with
Digital Medicine and
software solutions.
Biofourmis Wins Two Awards for Hospital@Home Solution
Kuldeep Singh Rajput named on Boston Business Journal 2021 40 Under 40
America’s Most Promising Artificial Intelligence Companies
Biofourmis named Idol Disrupt Winner
Annual ranking of the 150 most promising digital health startups in the world
FierceHealthcare’s Fierce 15 Award in 2020
Breakthrough COVID-19 Technology Quarterfinalist
Top 50 RPM Companies in 2022
Learn more about how you can accelerate innovation with digital medicine to improve patient outcomes.
)
)
)